http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Check Point Software to Announce 2025 First Quarter Financial Results on April 23, 2025
-
Hyundai Motor America Reports Record-Breaking March 2025 and Q1 Sales
-
HomeServe Awards 20 Apprentice and Training Grants to Support Skilled Trades Workforce
-
ESGold Advances Subsurface Imaging at Montauban as ANT Survey Enters Final Phase
-
Ondas (ONDS) Secures $3.2M Order to Expand the Optimus Drone Infrastructure in the UAE
-
Clene to Present at the Jones Healthcare and Technology Innovation Conference
-
Amprius Sets April 2025 Events Schedule
-
Xigem Technologies Secures Funding to Support its EchoDigital Business Unit
-
High Wire Reports 2024 Continuing Operations Revenue Up 21% to Record $8.38 Million
-
IDC Predicts AI Solutions & Services will Generate Global Impact of $22.3 Trillion by 2030
-
Ondas Secures $3.2 Million Order to Expand the Optimus Drone Infrastructure in the UAE
-
Intercept Music Celebrates Indie Label Successes and Announces New Hire
-
Stratasys (SSYS) Expands Stereolithography Product Line - Unveils Neo®800+ High-Speed Large-Format Printer
-
Stratasys Expands Stereolithography Product Line - Unveils Neo®800+ High-Speed Large-Format Printer
-
Guardforce AI Launches DVGO, an AI Travel Planning Tool Powered by Specialized AI Agents, in the United States
-
Raadr Inc., Doing Business as Telvantis, Completes Final Stage of Legacy Debt Remediation, Paving the Way for New Growth Phase
-
Schneider Electric Introduces U.S. Public Sector Business: Schneider Electric Federal, Inc.
-
Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX
-
Hyundai IONIQ 6 Named 2025 Best Value EV by Cars.com
-
JOTO PR Unveils "Anti-PR AI Whisperer": First-Ever AI Therapist for Misunderstood CEOs
-
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
-
Digital Executive Protection: A Critical Imperative for Modern Leadership - Dr. Chris Pierson Sets the Stage at RSAC 2025
-
New Disaster Preparedness Fund Launched with $500,000 Grant from The Allstate Foundation to Strengthen Communities Against Future Disasters
-
BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees
-
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
-
Citizens Announces $2.6 Million in Financial Education Grants
-
Soluna Reports Revenue Growth of 80.5% to $38 Million for 2024
-
Recursion to Participate in Upcoming Investor Conference
-
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC
-
Ontario International Airport wins ADDY Award for marketing creativity for its "Not So Fast" TV commercial
-
Nasuni Appoints Sam King as Chief Executive Officer
-
SelectBlinds Launches Laura Ashley Window Coverings With Iconic Prints
-
Millennial Potash Initiates Phase 2 Drilling Program at Its Banio Potash Project in Gabon
-
Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference
-
MDA Space To Acquire Satixfy Communications (SATX)
-
MDA SPACE TO ACQUIRE SATIXFY COMMUNICATIONS
-
Korro Bio (KRRO) Appoints Loïc Vincent as Chief Scientific Officer
-
Organon (OGN) Acquires TOFIDENCE
-
LeddarTech Enters Into Further Amendments to Credit Facility and Bridge Financing Offer and Announces Receipt of Nasdaq Deficiency Notice
-
Calamos Announces Upside Cap Rates for CPSP and CPRA: Structured Protection ETFs Providing Exposure to S&P 500 and Russell 2000 with 100% Downside Protection Over One Year
-
Context Therapeutics to Participate in Upcoming Investor Conferences
-
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System
-
Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.
-
Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer
-
Blackline Safety Sees 175% Surge in Fire-Hazmat Customers Last Year, Now Protecting 350 Fire Departments Globally
-
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
-
Apellis Pharmaceuticals (APLS) Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
-
Genomenon Unlocks Real-World Evidence for Precision Therapeutics Developers
-
Aviceda Therapeutics Appoints Industry Veteran Dr. Jeffrey Nau as Chief Executive Officer to Lead Next Phase of Growth and Innovation
-
Novocure to Report First Quarter 2025 Financial Results

